Senores Pharmaceuticals Limited (NSE:SENORES)

Senores Pharmaceuticals Revenue

Senores Pharmaceuticals had revenue of 1.80B INR in the quarter ending June 30, 2026, with 38.30% growth. This brings the company's total for the last twelve months to 6.80B, up 51.49% year-over-year. In the fiscal year ending March 31, 2026, Senores Pharmaceuticals had annual revenue of 6.33B with 58.85% growth. That makes Senores Pharmaceuticals the 25,189th largest company in the world by revenue and 1,552nd in India.

• Revenue (ttm): 6.80B
• Revenue Growth: +51.49%
• P/S Ratio: 8.29
• Revenue / Employee: 18.49M
• Employees: 368
• Market Cap: 56.37B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• outside India 4.84B 76.5%
• India 1.49B 23.5%

Fiscal year ended Mar 31, 2026 See the full Senores Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.33B	2.34B	58.85%
Mar 31, 2025	3.98B	1.84B	85.65%
Mar 31, 2024	2.15B	1.79B	507.07%
Mar 31, 2023	353.37M	211.67M	149.38%
Mar 31, 2022	141.70M	-	-

Data Source: S&P Global Market Intelligence Last updated: Jul 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error